Cyclopharm Limited (ASX: CYC)
Australia flag Australia · Delayed Price · Currency is AUD
2.120
-0.010 (-0.47%)
Jan 21, 2025, 4:10 PM AEST

Cyclopharm Company Description

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally.

The company operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism.

This segment also distributes products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases.

The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.

Cyclopharm Limited
Country Australia
Founded 1986
Industry Medical Distribution
Sector Healthcare
Employees 87
CEO James McBrayer

Contact Details

Address:
1 The Crescent
Kingsgrove, 2208
Australia
Phone 61 2 9541 0411
Website cyclopharm.com

Stock Details

Ticker Symbol CYC
Exchange Australian Securities Exchange
Fiscal Year January - December
Reporting Currency AUD
ISIN Number AU000000CYC5
SIC Code 3845

Key Executives

Name Position
James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDM Chief Executive Officer, MD, Company Secretary and Director
Mathew Farag Chief Operating Officer
Graham N. Phillips Finance Manager
Sally-Ann Cornelius Head of Sales
Niamh McAree Head of Quality and Regulatory
Chris Quinn Head of Service
Sui Ling Cheah Financial Controller
Lynn McLauchlin General Manager of Canada
Gary T. Somerville Quality and Regulatory Manager